BERKELEY, CA (UroToday.com) - The androgen receptor (AR) plays a critical role in the progression of prostate cancer, and it has been demonstrated previously that silencing the AR results in tumor growth inhibition and decreases in prostate specific antigen (PSA).[1,2]